Correction to: EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary (Diabetologia, (2024), 67, 11, (2375-2392), 10.1007/s00125-024-06196-3)

European Association for the Study of the Liver, European Association for the Study of Diabetes, European Association for the Study of Obesity

Research output: Contribution to journalComment/Debate

Abstract

This paper was erroneously published under a non-Open Access license. The article is forthwith distributed under the terms of Creative Commons Attribution 4.0 International License. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The article also incorrectly included ‘Clinical Practice Guideline Panel’ in the author line. The original article has been corrected.

Original languageEnglish
Pages (from-to)2608
Number of pages1
JournalDiabetologia
Volume67
Issue number11
DOIs
StatePublished - Nov 2024

Bibliographical note

Publisher Copyright:
© The Author(s) 2024.

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Fingerprint

Dive into the research topics of 'Correction to: EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary (Diabetologia, (2024), 67, 11, (2375-2392), 10.1007/s00125-024-06196-3)'. Together they form a unique fingerprint.

Cite this